A Maynard, K Bloor. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisDrug CostsDrug Industry/economicsDrug Industry/legislation & jurisprudenceHealth ExpendituresResearch Support as TopicState Medicine/economicsUnited Kingdom
Year: 1997 PMID: 9253257 PMCID: PMC2127150 DOI: 10.1136/bmj.315.7102.200
Source DB: PubMed Journal: BMJ ISSN: 0959-8138